Alexandria Real Estate Equities
ARE
#2280
Rank
A$11.96 B
Marketcap
A$69.51
Share price
-0.39%
Change (1 day)
-45.57%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -A$0.9 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are A$2.76 Billion. In 2025 the company made an earning of -A$1.42 Billion a decrease over its 2024 earnings that were of A$0.99 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.9 Billion-36.7%
2025 -A$1.42 Billion-242.13%
2024 A$0.99 B96.11%
2023 A$0.50 B-53.56%
2022 A$1.09 B-3.96%
2021 A$1.14 B-20.26%
2020 A$1.43 B72.88%
2019 A$0.82 B3.11%
2018 A$0.80 B73.54%
2017 A$0.46 B464.88%
2016 A$81.95 M-77.32%
2015 A$0.36 B36.31%
2014 A$0.26 B-10.81%
2013 A$0.29 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$9.90 B-1,282.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.17 B-5,849.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.75 B-1,860.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$2.81 Billion 234.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.66 B-298.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.07 B-2,138.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.61 B-292.46%๐Ÿ‡บ๐Ÿ‡ธ USA